The multi-year partnership will target severe liver and heart conditions, with insitro eligible for up to $1.46 billion in development and commercial milestone payments
If the strike goes ahead, it would hit the state's main free emergency ambulance network, with about 3,200 ambulance drivers and EMTs unavailable from Wednesday night
Private equity giants are betting on India’s hospital sector, with smaller cities emerging as a key growth market. But will more hospital beds mean affordable healthcare for patients? Here’s what the
Beyond universal coverage, India needs health care facilities that deliver timely, reliable and quality care, not merely exist
Google's Fitbit Edge features an OLED display, built-in GPS, health tracking, AI-powered fitness guidance, and up to seven days of battery life
Bengaluru-based healthtech firm Tricog Health, which combines medical-grade AI, connected diagnostic technology, and specialist clinical expertise to deliver cardiac diagnosis, is targeting 100 million cardiac screenings by 2030. The company, founded in 2014, has screened over 41 million patients and currently screens over a million patients globally every month, Tricog Health Founder and CEO Dr Charit Bhograj told PTI in an interaction. Tricog Health, which began public health partnerships with the Goa government in 2018, has since expanded to Maharashtra, Telangana, Odisha, Bihar, Karnataka, and Manipur. It also operates in 14 Global South countries, including the Philippines, Malaysia, and Kenya. The expansion comes amid projections that cardiovascular disease will remain the single largest killer in India well beyond 2050, with one in five heart attacks occurring before age 45, Bhograj said. India has about 6,500 cardiologists and 50,000 physicians, as per estimates. According
Max Healthcare's Abhay Soi discusses the economics of hospital care, regulatory scrutiny of medicine mark-ups and reforms needed to improve affordability and expand healthcare capacity
The Supreme Court has directed the Centre to constitute a committee to examine statutory regulations on pharmaceutical marketing, including gifts and incentives offered to doctors
The Supreme Court asks the Centre and amicus curiae to propose a permanent corpus for SMA patients, funded through CSR contributions and government grants to ensure treatment support
UK health science firm partners with Kynora Life Sciences to launch DNA and epigenetics testing kits priced between ₹25,000 and ₹85,000, targeting personalised wellness in India
Google has launched the Fitbit Air in India at Rs 13,999. The screenless fitness tracker offers heart rate, sleep and SpO2 monitoring, up to seven days of battery life and AI-powered health insights
Going ahead, analysts suggest investors stick to domestic economy-focused sectors as the geopolitical situation still warrants caution.
According to reports, the Supreme Court flagged concerns over the wide gap between the price-to-retailer and maximum retail price of essential medicines.
IHH says India remains a key strategic market as it plans to deepen its Fortis investment, despite a Supreme Court-ordered forensic audit into past transactions
PFRDA's NPS Swasthya combines healthcare withdrawals with a super top-up cover, while Irdai proposes tighter commissions and expense limits to curb mis-selling and lower distribution costs
In the first half of September, healthcare saw FPI inflows of ₹2,114 crore, the highest among all sectors, adding to the ₹5,931 crore and ₹7,755 crore buying seen in August and July, respectively.
The quick commerce platform plans to expand its Delhi-NCR network from three to over 15 dark stores and target an annual run rate of more than Rs 150 crore
The BSE Healthcare index rallied over 1% in Monday's trade. Thus far in the financial year 2026-27, it outperformed the market by soaring 25%, against a near 4% rise in the BSE Sensex.
Mumbai-based Vytalyou has raised Rs 8-10 crore at a valuation of around Rs 33 crore to expand its network in Mumbai and enter other major Indian cities in 2027
Industry bodies back greater scrutiny of medical device pricing but differ on how gaps between hospital procurement costs and prices charged to patients should be assessed